Navidea Biopharmaceuticals (FRA:NO1A) Short-Term Capital Lease Obligation : €0.01 Mil (As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Navidea Biopharmaceuticals Short-Term Capital Lease Obligation?

Navidea Biopharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was €0.01 Mil.

Navidea Biopharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Mar. 2023 (€0.01 Mil) to Jun. 2023 (€0.02 Mil) but then declined from Jun. 2023 (€0.02 Mil) to Sep. 2023 (€0.01 Mil).

Navidea Biopharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (€0.24 Mil) to Dec. 2021 (€0.24 Mil) but then declined from Dec. 2021 (€0.24 Mil) to Dec. 2022 (€0.02 Mil).

Navidea Biopharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Navidea Biopharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navidea Biopharmaceuticals Short-Term Capital Lease Obligation Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.11

0.23

0.24

0.02

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.03	0.02	0.01	0.02	0.01

Navidea Biopharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Navidea Biopharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Navidea Biopharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Navidea Biopharmaceuticals (FRA:NO1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Navidea Biopharmaceuticals Inc (FRA:NO1A) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NAVB:USA

Address

4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website

https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Navidea Biopharmaceuticals (FRA:NO1A) Headlines

No Headlines